These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7484741)

  • 1. Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy.
    Yoneya K; Okamoto H; Machida M; Onozuka H; Noguchi M; Mikami T; Kawaguchi H; Murakami M; Uede T; Kitabatake A
    Am Heart J; 1995 Nov; 130(5):1089-93. PubMed ID: 7484741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy.
    Ishanov A; Okamoto H; Yoneya K; Watanabe M; Nakagawa I; Machida M; Onozuka H; Mikami T; Kawaguchi H; Hata A; Kondo K; Kitabatake A
    Am Heart J; 1997 Feb; 133(2):184-9. PubMed ID: 9023164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme and angiotensinogen gene polymorphism in hypertrophic cardiomyopathy.
    Kawaguchi H
    Exp Clin Cardiol; 2003; 8(3):155-9. PubMed ID: 19641710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes on the phenotypic expression of Spanish patients with hypertrophic cardiomyopathy].
    López-Haldón J; García-Lozano JR; Martínez Martínez A; Núñez-Roldán A; Burgos Cornejo J
    Med Clin (Barc); 1999 Jul; 113(5):161-3. PubMed ID: 10480137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
    Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
    Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
    Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
    Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy.
    Luo R; Li X; Wang Y; Li Y; Deng Y; Wan Y; Jiang Z; Hua W; Wu X
    PLoS One; 2013; 8(10):e77030. PubMed ID: 24204726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy.
    Doolan G; Nguyen L; Chung J; Ingles J; Semsarian C
    Int J Cardiol; 2004 Aug; 96(2):157-63. PubMed ID: 15314809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.
    Marian AJ; Yu QT; Workman R; Greve G; Roberts R
    Lancet; 1993 Oct; 342(8879):1085-6. PubMed ID: 8105312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of cardiac function by biochemical and molecular biological techniques].
    Kawaguchi H
    Rinsho Byori; 1998 Apr; 46(4):354-8. PubMed ID: 9594626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy.
    Buck PC; Fernandes F; Arteaga E; Matsumoto AY; Araujo AQ; Oliveira EM; Ianni BM; Ramires FJ; Krieger JE; Mady C
    Braz J Med Biol Res; 2009 Aug; 42(8):717-21. PubMed ID: 19390744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy.
    Ogimoto A; Hamada M; Nakura J; Miki T; Hiwada K
    J Hum Genet; 2002; 47(4):184-9. PubMed ID: 12166654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between angiotensin converting enzyme gene I/D polymorphism and QT dispersion in patients with hypertrophic cardiomyopathy.
    Kaya CT; Gurlek A; Altin T; Kilickap M; Karabulut HG; Turhan S; Ozcan O; Bokesoy I; Oral D; Erol C
    J Renin Angiotensin Aldosterone Syst; 2010 Sep; 11(3):192-7. PubMed ID: 20478904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy].
    Pan GZ; Liu WL; Hu DY; Xie WL; Zhu TG; Li L; Li CL; Bian H
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2998-3001. PubMed ID: 17288815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.
    Wang SX; Fu CY; Zou YB; Wang H; Shi Y; Xu XQ; Chen JZ; Song XD; Huan TJ; Hui RT
    Chin Med J (Engl); 2008 Jan; 121(1):27-31. PubMed ID: 18208662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Hernández-Romero D; Orenes-Piñero E; García-Honrubia A; Climent V; Romero-Aniorte AI; Martínez CM; García-Bautista M; Martínez M; Feliu E; González J; Cánovas S; Montero-Argudo JA; Valdés M; Marín F
    J Intern Med; 2015 Jul; 278(1):50-8. PubMed ID: 25476756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rs4646994 polymorphism of angiotensin-converting enzyme on the risk of nonischemic cardiomyopathy.
    Shen J; Qian X; Mei X; Yao J; Jiang H; Li K; Chen T; Jiang Y; Zhou Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy. Insertion-deletion polymorphism of angiotensin-converting enzyme and angiotensin II receptor.
    Gilanowska G; Domal-Kwiatkowska D; Smolik S; Wilczewski P; Szarek J; Nowalany-Kozielska E; Mazurek U; Wodniecki J; Wilczok T
    Kardiol Pol; 2005 May; 62(5):440-9; 449-50. PubMed ID: 15928721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.
    Ogimoto A; Okayama H; Nagai T; Ohtsuka T; Suzuki J; Inoue K; Nishimura K; Saito M; Shigematsu Y; Hamada M; Miki T; Higaki J
    J Cardiovasc Pharmacol; 2010 May; 55(5):506-10. PubMed ID: 20179607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.